Get started Log in

HLVX — HilleVax Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Brief: Hillevax Q1 Net Income USD -46.829 Million
09/05/2024 21:05
Brief: Hillevax Files For Mixed Shelf Of Upto $500 Mln - SEC Filing
20/03/2024 20:59
Brief: Hillevax Q4 Net Income USD -36.96 Million
20/03/2024 20:00
Brief: Hillevax And Kangh Announce Exclusive License Agreement For Norovirus Vaccine Candidate Outside Of China
08/01/2024 13:23
Brief: Hillevax Q3 Net Income USD -31.815 Million
09/11/2023 21:05
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx
20/09/2023 19:41
HilleVax rallies after $100 mln stock offering
20/09/2023 17:22
Brief: Hillevax Announces Pricing Of Public Offering Of Common Stock
20/09/2023 01:07
Brief: Hillevax Announces Proposed Public Offering Of Common Stock
19/09/2023 22:45
U.S. RESEARCH ROUNDUP-Dollar Tree, Hexcel, Humacyte
15/08/2023 08:18
Brief: Hillevax Q2 Net Income USD -27.902 Million
14/08/2023 12:00
Brief: Hillevax Inc Files For Mixed Shelf Of Up To $500 Million - SEC Filing
12/05/2023 22:02
Brief: Hillevax Reports First Quarter 2023 Financial Results And Highlights Recent Company Progress
12/05/2023 21:09
Brief: Hillevax Q1 Basic EPS USD -0.71
12/05/2023 21:05
Brief: Hillevax Announces Appointment Of Nanette Cocero Ph.D., Mba, To Its Board Of Directors
09/05/2023 13:05
Brief: HilleVax Announces Completion Of Enrollment Of NEST-IN1 Phase 2b Clinical Study Of HIL-214 Norovirus Vaccine Candidate
25/04/2023 14:04
U.S. RESEARCH ROUNDUP-Adobe, Nike, Roper Technologies
22/03/2023 07:30
Brief: Hillevax Reports Full Year 2022 Financial Results And Highlights Recent Company Progress
17/03/2023 20:10
Brief: Hillevax Announces Executive Management Appointments And Promotions
09/01/2023 13:42
Brief: HilleVax Announces Positive Immunogenicity Results For Run-In Cohort Of NEST-IN1 Phase 2b Clinical Trial Of HIL-214 Norovirus Vaccine Candidate
05/12/2022 11:40